Last updated on April 2019

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC


Brief description of study

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

Clinical Study Identifier: NCT03215706

Contact Investigators or Research Sites near you

Start Over

Local Institution

Habikino-shi, Japan
1.81miles
  Connect »

Local Institution

Osaka-shi, Japan
7.1miles
  Connect »

Local Institution

Osaka-sayama-shi, Japan
7.3miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.